INTRAVENOUS OR SUBCUTANEOUS ANALGESIC ADMINISTRATION SHOULD BE USED ONLY AS ALTERNATIVE TO "SIMPLER, LESS COSTLY" METHODS, AHCPR SAYS IN GUIDELINE
This article was originally published in The Gray Sheet
Executive Summary
Intravenous or subcutaneous administration of analgesics for cancer pain should be used only when "simpler, less demanding, and less costly methods are inappropriate or ineffective," an HHS Agency for Health Care Policy and Research panel concludes in a clinical practice guideline on management of cancer pain released March 3.